zdj3d3qi | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Luo%2C_Pan%3B_Liu%2C_Dong%3B_Li%2C_Juan>
?:doi	10.1136/ejhpharm-2020-002295
?:doi	<https://research.tib.eu/covid-19/entity/10.1136/ejhpharm-2020-002295>
?:journal	Eur_J_Hosp_Pharm
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/73dbf52d7938abf2a4442fe3fd97a46aee9cadfa.json
?:pmc_json_files	document_parses/pmc_json/PMC7299642.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7299642>
?:pmid	<https://research.tib.eu/covid-19/entity/32471815.0>
?:pmid	32471815.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/73dbf52d7938abf2a4442fe3fd97a46aee9cadfa>
?:source	Medline; PMC
?:title	Epinephrine use in COVID-19: friend or foe?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-05-29

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/zdj3d3qi>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/zdj3d3qi>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all